Norditropin 15iu (5mg)

Norditropin 15iu (5mg)

Norditropin 15iu (5mg) is a prescription somatropin injection containing recombinant human growth hormone in a 5 mg/1.5 mL formulation. Since 1 mg of somatropin corresponds to 3 IU, the complete 5 mg presentation provides the equivalent of 15 IU of somatropin. Norditropin is manufactured by Novo Nordisk and is intended for medically supervised growth hormone replacement or treatment where somatropin has been specifically prescribed.

The product is supplied as a sterile solution for subcutaneous injection. Norditropin SimpleXx presentations use a 1.5 mL cartridge designed for use with the appropriate compatible injection system. Product presentation can vary between countries, so the labeling and device supplied with the individual pack should always be checked before use.

Product Information

• Product Name: Norditropin 15iu (5mg)
• Brand: Norditropin
• Active Ingredient: Somatropin
• Medicine Type: Recombinant Human Growth Hormone
• Strength: 5 mg/1.5 mL
• Equivalent Amount: 15 IU
• Concentration: Approximately 3.3 mg/mL
• Dosage Form: Solution for injection
• Administration Route: Subcutaneous
• Manufacturer: Novo Nordisk
• Prescription Status: Prescription medicine

Formulation and Presentation

Each Norditropin 15iu (5mg) presentation contains 5 mg of somatropin in 1.5 mL of solution. Somatropin is produced using recombinant DNA technology and has the same amino-acid sequence as naturally occurring human growth hormone.

The solution should appear clear and colorless. The formulation also contains excipients used to maintain product stability and quality, including mannitol, histidine, phenol, poloxamer 188, water for injection, and ingredients used for pH adjustment.

Do not use the product if the solution appears cloudy, discolored, frozen, or contains visible particles. The cartridge and outer packaging should also be checked for damage before use.

Prescription Use

Norditropin is prescribed for specific conditions where growth hormone therapy is clinically indicated. Depending on local approved prescribing information, these may include growth failure caused by growth hormone deficiency and certain other medically diagnosed growth disorders in children.

Somatropin may also be prescribed to adults with confirmed growth hormone deficiency when replacement therapy is considered appropriate by a healthcare professional.

The required dose is individualized. Factors such as diagnosis, age, body weight, clinical response, laboratory monitoring, and other patient-specific considerations may influence the prescribed dose.

Norditropin 15iu (5mg) should not be treated as a routine bodybuilding, sports-performance, weight-loss, anti-aging, or cosmetic product. It is a prescription growth hormone medicine that requires appropriate medical assessment and supervision.

Storage Requirements

Unopened Norditropin should generally be stored in a refrigerator at 2°C to 8°C and protected from light. The product must not be frozen or stored directly beside a refrigerator cooling element.

Storage requirements after first use depend on the particular Norditropin presentation and market-specific instructions. Follow the storage period and temperature stated on the supplied carton and patient information leaflet.

Keep the cartridge or injection device protected when not in use. A needle should not remain attached during storage. Injection equipment intended for an individual patient should not be shared with another person.

Safety Information

Norditropin is not suitable for every patient. Somatropin has specific contraindications, precautions, and monitoring requirements. Treatment may require monitoring of glucose metabolism, thyroid function, adrenal function, growth response, and other clinical parameters.

Possible adverse effects may include injection-site reactions, headache, fluid retention, joint discomfort, muscle discomfort, and changes in glucose metabolism. Serious or persistent symptoms should be medically evaluated.

Somatropin should not be used in certain situations, including active malignancy, specific acute critical illnesses, or known hypersensitivity to somatropin or ingredients in the formulation. Growth-promoting treatment is also not appropriate for children whose growth plates have already closed.

Product Check Before Use

Before using Norditropin 15iu (5mg), confirm the product name, 5 mg/1.5 mL strength, expiry date, packaging integrity, prescribed dose, and required storage conditions.

Use Norditropin only according to the prescription, product leaflet, and instructions provided by the treating healthcare professional. The exact packaging and injection system supplied may vary by country or market.